2015
DOI: 10.4236/wjcd.2015.512040
|View full text |Cite
|
Sign up to set email alerts
|

Routine Primary PCI; Whether and When Necessary for the Management of NSTEMI—An Evidence Based Evaluation

Abstract: Non ST elevated myocardial infarction (NSTEMI) accounts for a significant portion of the hospitalizations due to acute coronary syndromes worldwide and is posing a huge challenge towards the health care cost globally. This signifies the need for proper triage and management stratification for the best utilization of the health care resources. Primary Percutaneous Coronary Intervention (PCI) with early revascularization is a new emerging invasive technique and application of this technique is increasing tedious… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2016
2016
2018
2018

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 19 publications
0
1
0
1
Order By: Relevance
“…13 Sementara itu, pasien yang datang antara 12 hingga 48 jam setelah timbulnya gejala, bahkan jika tanpa angina dan dengan hemodinamik yang stabil, dikatakan masih mendapat manfaat dari angiografi koroner dini dan mungkin PCI. 13,17,18 Penelitian dari Schömig…”
Section: Diskusiunclassified
“…13 Sementara itu, pasien yang datang antara 12 hingga 48 jam setelah timbulnya gejala, bahkan jika tanpa angina dan dengan hemodinamik yang stabil, dikatakan masih mendapat manfaat dari angiografi koroner dini dan mungkin PCI. 13,17,18 Penelitian dari Schömig…”
Section: Diskusiunclassified
“…HF is a major public health issue with substantial mortality and morbidity which also poses a challenge to clinical diagnosis and generally affects the older segment of the population [4] [5]. Various clinical conditions including ischemic and non-ischemic heart diseases, metabolic and endocrine diseases, infectious and chronic diseases, use of cardiac and non-cardiac cardiotoxic drugs are some of the common factors causing HF [6]- [11]. The prevalence of HF has an increasing trend with 23 million people worldwide being affected in 2011 alone [4].…”
Section: Introductionmentioning
confidence: 99%